- Title
- Aquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone
- Creators
- Eric C.-Y LIAN - Division of Hematology/Oncology, University of Miami School of Medicine/Sylvester Cancer Center/Veterans Affairs Medical Center, Miami, Florida, United StatesMary Jo VILLAR - Division of Hematology/Oncology, University of Miami School of Medicine/Sylvester Cancer Center/Veterans Affairs Medical Center, Miami, Florida, United StatesLionel I NOY - Division of Hematology/Oncology, University of Miami School of Medicine/Sylvester Cancer Center/Veterans Affairs Medical Center, Miami, Florida, United StatesZoneddy RUIZ-DAYAO - Division of Hematology/Oncology, University of Miami School of Medicine/Sylvester Cancer Center/Veterans Affairs Medical Center, Miami, Florida, United States
- Publication Details
- American journal of hematology, Vol.69(4), pp.294-295
- Publisher
- Wiley-Liss; New York, NY
- Academic Unit
- Human Resources; Benefits - Other
- Language
- English
- Resource Type
- Journal article
- PMID
- 11921026
- Record Identifier
- 991031562385302976
Journal article
Aquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone
American journal of hematology, Vol.69(4), pp.294-295
2002
PMID: 11921026
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.75 Blood Clotting
- 1.75.619 Haemophilia
- Web Of Science research areas
- Hematology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites